On-Demand Clinical
Webinars

Topics

Show all Glucose Lactate Critical Care Magnesium
Neonate Pediatric Regulatory Sepsis Creatinine

Languages

English French Italian German Chinese
Portuguese Spanish

Monitoraggio del Glucosio ematico: E’ sicuro per i pazienti critici?
Germano Ferrari, PhD
Direttore degli Affari Medici e Scientifici - Europa
Nova Biomedical



Misura del Lattato in Point-of-care: uno strumento essenziale nella gestione del paziente settico
Germano Ferrari, PhD
Direttore degli Affari Medici e Scientifici - Europa
Nova Biomedical



The Diagnostic Approach to Patients with Sepsis
Evan Ntrivalas, MD, PhD
Director of Medical and Scientific Affairs
Nova Biomedical


Bedside glucose testing in critically ill patients: The importance of improved accuracy
Martha E. Lyon, PhD, DABCC, FACB
Clinical Biochemist/ Royal University Hospital



Clinical Impact of Blood Glucose Monitoring Accuracy in Critical Care
Nam K. Tran, PhD, MS, FACB-Associate Clinical Professor & Director of Clinical
Chemistry and Point-of-Care Testing



Das Management von Dysglykämie mit POCT: Geräte-Technologie und -Performance Betrachtung
Georg Montanus /Dipl. Ing./ Medizintechnik (FH)/ Produktspezialist/ Nova Biomedical GmbH/ Mörfelden-Walldorf



Glucose meter use in critically ill patients: Why improved meter accuracy may lead to better ICU outcomes
Brad S. Karon, MD, PhD
Professor of Laboratory Medicine & Pathology
Director, Point of Care Testing & Hospital Clinical Labs Mayo Clinic, Rochester, MN



Glu-床旁血糖监测-对重症病人来说安全吗?
裘玮 Wei Qiu
医学科学事物部中国区总监
美国 Nova Biomedical 公司



iMg -对危重病人进行游离镁离子检测的重要性
裘玮 Wei Qiu
医学科学事物部中国区总监
美国 Nova Biomedical 公司



Impacto Clínico da Precisão dos Medidores Portáteis de Glicose em pacientes hospitalizados
Federico Montealegre, DVM, MS, PhD, PhD
Director, Departamento Medico y Científic



Impacto Clínico de la Presición de los Medidores Portátiles de Glucosa en Cuidados Intensivos
Federico Montealegre, DVM, MS, PhD, PhD
Director, Departamento Medico y Científic



Choosing the right sample for glucose POCT: BRAVE criteria
Steven Cotten, PhD, DABCC, NACB, Assistant Professor Pathology & Director of Chemistry and Toxicology Ohio State University, Wexner Medical Center



Analyse d’un trouble acide-base selon la méthode qualitative classique et l’approche quantitative de Fencl-Stewart
Professeur Jacques Levraut-Chef du Département de Médecine d’Urgence-Hôpital Pasteur 2, Nice-Professeur de médecine d’urgence à l’université Nice Sophia –Antipolis-Chef du Département de Médecine d’Urgence à l’hôpital Pasteur 2 à Nice



La surveillance de la glycémie est-elle fiable pour les patients en soins intensifs ?
Charbel Abou-Diwan, PhD, D(ABCC), F(ACB) Directeur Affaires médicales et scientifiques Nova Biomedical


Mesure de la cétonémie comme outil de triage aux Urgences ?
Professeur Jacques Levraut
Professeur de médecine d’urgence à l’université Nice Sophia –Antipolis Chef du Pôle Urgences-SAMU-SMUR de l’hôpital l’Archet 2 à Nice


L'importance de mesurer le magnésium ionisé chez les patients en état critique
Germano Ferrari Ph.D.
Directeur Européen, Affaires Médicales et Scientifiques, Nova Biomedical


L'importanza della misurazione del magnesio ionizzato
Germano Ferrari
Dr Germano Ferrari, PhD, MBA Direttore Europeo, Affari Medici e Scientifici MASA- Nova Biomedical


Misura del Lattato in Point-of-care: uno strumento essenziale nella gestione del paziente settico
Germano Ferrari
Dr Germano Ferrari, PhD, MBA Direttore Europeo, Affari Medici e Scientifici MASA- Nova Biomedical


High Dose Vitamin C Therapy in Critically Ill Patients. False Hyperglycemia Associated with POC Glycemic Management
Alexander H. Flannery, PharmD, BCCCP, BCPS, Assistant Professor, Department of Pharmacy Practice and Science Director, PGY2 Critical Care Residency, University of Kentucky HealthCare and College of Pharmacy


The Importance of Measuring Ionised Magnesium in Critically Ill Patients
Andrei Malic (PhD) Clinical Communications Director, Medical and Scientific Affairs, Nova Biomedical


The Importance of Measuring Ionized Magnesium in Critically Ill Patients
Evan Ntrivalas, MD, PhD, Director, Medical and Scientific Affairs, Nova Biomedical


Bedside Glucose Monitoring – Is it Safe for Critically Ill Patients?
Andrei Malic, PhD, Director, Medical and Scientific Affairs, Nova Biomedical


The Clinical Impact of Improved Glucose Monitoring in Neonatal Intensive Care Pediatric Setting
Khosrow Adeli, PhD, FCACB, NACB, DABCC, Head and Professor, Clinical Biochemistry, The Hospital for Sick Children, University of Toronto


Lactate Monitoring for Severe Sepsis and Septic Shock: Are All Lactate Measurements the Same?
Nam K. Tran, PhD, MS, FACB, Associate Clinical Professor, Director of Clinical Chemistry and Point-of-Care Testing, Department of Pathology and Laboratory Medicine University of California, Davis



The Confusing Conundrum of Collecting and Measuring Glucose in Neonates
Martha Lyon, PhD, DABCC, FACB, Clinical Biochemist/Clinical, Associate Professor, Royal University Hospital, Saskatoon


New Regulatory and Accreditation Issues that Affect Hospital Glycemic Management Programs
Jeffery A. DuBois, PhD, HCLD/CC (ABB), FACP, VP Medical and Scientific Affairs, Nova Biomedical


Can Point-of-Care Creatinine Testing Reduce Contrast-Induced Acute Kidney Injury (CI-AKI) in STEMI Patients Treated with PPCI?
Thomas Keeble, MBBS, BSc, MRCP, MD, Consultant Cardiologist, Southend Hospital, Essex Cardiothoracic Centre, and Senior Clinical Fellow, Anglia Ruskin University


The Sepsis Epidemic: New Sepsis Definitions and Evidenced-Based Treatment
Ron Daniels, BEM, NHS Consultant in Critical Care and Anaesthesia, Co-Founder and Chief Executive, UK Sepsis Trust and CEO, Global Sepsis Alliance


Clinical Impact of Blood Glucose Monitoring System Accuracy in Critical Care
Nam K. Tran, PhD, MS, FACB, Assistant Clinical Professor, Director of Clinical Chemistry and Point-of-Care Testing, Department of Pathology and Laboratory Medicine, University of California, Davis


Point-of-Care Glucose in Critically Ill Patients– The Importance of Glucose Meter Accuracy
Arthur H. Combs, MD, FCCP, FCCM, President, FutureTech Strategies, Inc., Evan Ntrivalas, MD, PhD, Director, Medical and Scientific Affairs, Nova Biomedical


Glucose Meters and Glycemic Control: Does Meter Error Impact Glycemic Control Outcomes?
Brad S. Karon, MD, PhD, Associate Professor of Laboratory Medicine and Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic

 

 

Never miss a webinar; subscribe today!